Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Shijiazhuang Yiling Pharmaceutical Co Ltd's latest stock split occurred on Jul 7, 2021
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Shijiazhuang Yiling Pharmaceutical Co Ltd traded at 20.6571 per share. Afterward, the share price was about 19.2623.
The adjusted shares began trading on Jul 7, 2021. This was Shijiazhuang Yiling Pharmaceutical Co Ltd's 3rd stock split, following the previous one in May 20, 2015.
1S9
Shijiazhuang Yiling Pharmaceutical Co Ltd
Glance View
Shijiazhuang Yiling Pharmaceutical Co Ltd, rooted in the northern heart of China, embodies a harmonious blend of traditional Chinese medicine and modern pharmaceutical science. Born from the insightful vision of Wu Yiling, a prominent figure in integrating traditional Chinese medical practices with contemporary research methodologies, the company has grown into a significant player in the healthcare sector. Its foundation is deeply entrenched in leveraging ancient herbal wisdom while adopting cutting-edge biopharmaceutical technologies. At the core of its operations, Yiling Pharmaceutical specializes in the research, development, and production of therapeutic drugs aimed at treating chronic diseases and boosting immunity. This dual approach allows the company to carve out a niche in producing signature products like Lianhua Qingwen, a respiratory treatment renowned for its efficacy in alleviating symptoms from colds and flu. What powers Yiling Pharmaceutical's continued growth is its steadfast commitment to research and development, translated into a structured pipeline of innovative drugs. The company's funding funnel directs substantial resources into ongoing research, ensuring a constant expansion and refinement of their product portfolio. With an emphasis on effectiveness backed by rigorous scientific validation, Yiling has successfully navigated the complexities of pharmaceutical regulations, extending its reach beyond domestic borders to international markets. This expansionist strategy, coupled with a deep understanding of traditional medicine, forms a robust revenue stream, encapsulating both the domestic market's demand for traditional therapies and the international community's growing interest in alternative medicine solutions. Through these channels, Yiling harmonizes its traditional roots with a forward-thinking business model, ensuring steady financial footholds and promising horizons.
You don't have any saved screeners yet